SLC22A5 Antikörper
-
- Target Alle SLC22A5 Antikörper anzeigen
- SLC22A5 (Solute Carrier Family 22 Member 5 (SLC22A5))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLC22A5 Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (IF)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human SLC22A5 (NP_003051.1).
- Isotyp
- IgG
- Top Product
- Discover our top product SLC22A5 Primärantikörper
-
-
- Applikationshinweise
- IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- SLC22A5 (Solute Carrier Family 22 Member 5 (SLC22A5))
- Andere Bezeichnung
- SLC22A5 (SLC22A5 Produkte)
- Hintergrund
- Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants.
- Molekulargewicht
-
Observed_MW: 70kDa
Calculated_MW: 24kDa/62kDa/65kDa
- Gen-ID
- 6584
- UniProt
- O76082
-